Secondary offering of 8M shares by certain shareholders; company receives no proceeds

Harmony Biosciences Holdings, Inc.

Selling Shareholders sold 8,000,000 shares of common stock in a registered public offering.
Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares.
J.P. Morgan Securities LLC acted as the sole underwriter for the offering.
Company will not receive any proceeds from the sale; all net proceeds go to Selling Shareholders.
Offering closed on November 1, 2024, under an Underwriting Agreement dated October 30, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.